BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36030073)

  • 1. Challenges in anticoagulation for patients with brain tumors.
    Iyengar V; Patell R; Zwicker J
    Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
    Lin RJ; Green DL; Shah GL
    Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding.
    Becattini C; Cimini LA; Carrier M
    Thromb Res; 2021 Apr; 200():41-47. PubMed ID: 33529872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors.
    Carney BJ; Uhlmann EJ; Puligandla M; Mantia C; Weber GM; Neuberg DS; Zwicker JI
    J Thromb Haemost; 2019 Jan; 17(1):72-76. PubMed ID: 30450803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic anticoagulation for venous thromboembolism after recent brain surgery: Evaluating the risk of intracranial hemorrhage.
    de Melo Junior JO; Lodi Campos Melo MA; da Silva Lavradas LA; Ferreira Lopes PG; Luiz Ornelas II; de Barros PL; da Mata Pereira PJ; Niemeyer Filho P
    Clin Neurol Neurosurg; 2020 Oct; 197():106202. PubMed ID: 32916398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of direct oral anticoagulants versus low-molecular-weight heparin in primary and metastatic brain cancers: a meta-analysis and systematic review.
    Iyengar V; Agrawal S; Chiasakul T; Tehranchi K; Mcnichol M; Carney BJ; Leader A; Zwicker JI; Patell R
    J Thromb Haemost; 2024 Feb; 22(2):423-429. PubMed ID: 37866517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation.
    Zwicker JI; Karp Leaf R; Carrier M
    J Thromb Haemost; 2016 Sep; 14(9):1736-40. PubMed ID: 27306689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of intracranial hemorrhage with direct oral anticoagulation versus low molecular weight heparin in the treatment of brain tumor-associated venous thromboembolism: A meta-analysis.
    Yang J; He Z; Li M; Hong T; Ouyang T
    J Stroke Cerebrovasc Dis; 2023 Aug; 32(8):107243. PubMed ID: 37413715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in the Setting of Primary and Metastatic Brain Tumors.
    Mantia C; Zwicker JI
    Cancer Treat Res; 2019; 179():179-189. PubMed ID: 31317488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis.
    Porfidia A; Giordano M; Sturiale CL; D'Arrigo S; Donadini MP; Olivi A; Ageno W; Pola R
    Brain Behav; 2020 Jun; 10(6):e01638. PubMed ID: 32314875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis.
    Rojas-Hernandez CM; Oo TH; García-Perdomo HA
    J Thromb Thrombolysis; 2017 Feb; 43(2):233-240. PubMed ID: 27704333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
    Diaz M; Jo J
    Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Direct Oral Anticoagulants in Central Nervous System Malignancies.
    Swartz AW; Drappatz J
    Oncologist; 2021 May; 26(5):427-432. PubMed ID: 33523555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resuming anticoagulant therapy after intracerebral bleeding.
    Becattini C; Sembolini A; Paciaroni M
    Vascul Pharmacol; 2016 Sep; 84():15-24. PubMed ID: 27260938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial hemorrhage in cancer patients treated with anticoagulation.
    Weinstock MJ; Uhlmann EJ; Zwicker JI
    Thromb Res; 2016 Apr; 140 Suppl 1():S60-5. PubMed ID: 27067980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation Is Associated with Decreased Inferior Vena Cava Filter-Related Complications in Patients with Metastatic Carcinoma.
    Mahmood SS; Abtahian F; Fogerty AE; Cefalo P; MacKay C; Jaff MR; Weinberg I
    Am J Med; 2017 Jan; 130(1):77-82.e1. PubMed ID: 27477669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of venous thromboembolism.
    Wells PS; Forgie MA; Rodger MA
    JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
    Witt DM; Clark NP; Martinez K; Schroeder A; Garcia D; Crowther MA; Ageno W; Dentali F; Ye X; Hylek E; Delate T
    Thromb Res; 2015 Nov; 136(5):1040-4. PubMed ID: 26454758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of long-term anticoagulation in patients with brain metastases.
    Horstman H; Gruhl J; Smith L; Ganti AK; Shonka NA
    Med Oncol; 2018 Mar; 35(4):43. PubMed ID: 29497873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.